Pura Vida Investments’s Edwards Lifesciences EW Stock Holding History

Pura Vida Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,408	Closed	-$1.47M	–	53
2024 Q1	$1.47M	Buy	+15,408	New	+$1.29M	0.25%	40
2022 Q3	–	Sell	-20,700	Closed	-$1.97M	–	219
2022 Q2	$1.97M	Buy	+20,700	New	+$2.14M	0.11%	141
2018 Q2	–	Sell	-75,000	Closed	-$3.49M	–	102
2018 Q1	$3.49M	Buy	+75,000	New	+$3.26M	2.06%	18
2015 Q4	–	Sell	-105,000	Closed	-$2.73M	–	79
2015 Q3	$2.49M	Sell	105,000 -45,000	-30%	-$1.09M	1.42%	32
2015 Q2	$3.8M	Sell	150,000 -90,000	-38%	-$2.03M	1.95%	17
2015 Q1	$5.7M	Sell	240,000 -210,000	-47%	-$4.71M	2.94%	7
2014 Q4	$9.55M	Buy	+450,000	New	+$9.04M	3.52%	4

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pura Vida Investments's EW Position: Q2 2024 in Review

Pura Vida Investments sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 15,408 shares — an estimated $1.47M sold.

Pura Vida Investments first reported a position in EW in Q4 2014 and held it in 7 quarters. The position peaked at $9.55M in Q4 2014. 1,295 funds tracked by Wall St. Rank hold EW as of Q2 2024.

Pura Vida Investments reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
Pura Vida Investments sold 15,408 Edwards Lifesciences shares in Q2 2024, an estimated $1.47M.
Pura Vida Investments first reported a position in Edwards Lifesciences in Q4 2014 and held it in 7 quarters.
Pura Vida Investments's Edwards Lifesciences position peaked at $9.55M in Q4 2014.
1,295 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.